Trial Profile
The efficacy and effects of ivabradine and bisoprolol in patients with stable coronary artery disease and stable angina pectoris
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Nov 2017
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary) ; Bisoprolol
- Indications Angina pectoris; Coronary artery disease
- Focus Therapeutic Use
- 23 Apr 2014 New trial record
- 31 Mar 2014 Results presented at the 63rd Annual Scientific Session of the American College of Cardiology.